Podcast: Play in new window | Download (Duration: 31:08 — 42.8MB)
Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More
When your health is on the line, accurate diagnostics are crucial. But many blood tests suffer from false positives, false negatives, and frustrating gray areas. In this episode of StartUp Health NOW, host Logan Plaster sits down with John Forrest, CEO & Co-founder of Veravas, a member of the StartUp Health community, to discuss their groundbreaking solution.
- VeraBIND: Learn how Veravas’ patented technology cleans blood samples to remove impurities, dramatically increasing diagnostic accuracy and eliminating ambiguous results.
- Transforming Alzheimer’s Detection: Find out how VeraBIND results in a test with a single result that says yes, you have the disease, or no, you don’t.
- Beyond Blood: Explore the potential of VeraBIND to transform diagnostics for a wide range of diseases, even using saliva samples – which are much easier for older patients to manage on a regular basis.
- The Future: Hear Forrest’s insights on the challenges and opportunities in the health tech industry and how Veravas is poised to make a significant impact.
Tune in for the conversation and learn how Veravas is turning the tide on diagnostic uncertainty.
Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.
Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.